Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma
- 28 January 2003
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 36 (2) , 53-59
- https://doi.org/10.1002/mc.10098
Abstract
In epithelial ovarian cancer, tumor grade is an independent prognosticator whose molecular determinants remain unknown. We investigated patterns of gene expression in well‐ and poorly differentiated serous papillary ovarian and peritoneal carcinomas with cDNA microarrays. A 6500‐feature cDNA microarray was used for comparison of the molecular profiles of eight grade III and four grade I stage III serous papillary adenocarcinomas. With a modified F‐test in conjunction with random permutations, 99 genes whose expression was significantly different between grade I and grade III tumors were identified (P < 0.01). A disproportionate number of these differentially expressed genes were located on the chromosomal regions 20q13 and all exhibited higher expression in grade III tumors. Interphase fluorescent in situ hybridization demonstrated 20q13 amplification in two of the four grade III and none of the three grade I tumors available for evaluation. Several centrosome‐related genes also showed higher expression in grade III tumors. We propose a model in which tumor differentiation is inversely correlated with the overexpression of several oncogenes located on 20q13, a common amplicon in ovarian and numerous other cancers. Dysregulation of centrosome function is one potential mechanistic link between genetic/epigenetic changes and the poorly differentiated phenotype in ovarian cancer. Published 2003 Wiley‐Liss, Inc.Keywords
This publication has 28 references indexed in Scilit:
- Comprehensive Genome Sequence Analysis of a Breast Cancer AmpliconGenome Research, 2001
- Characterization of chromosome aberrations associated with soft‐tissue leiomyosarcomas by twenty‐four‐color karyotyping and comparative genomic hybridization analysisGenes, Chromosomes and Cancer, 2001
- Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaThe Lancet, 2001
- Ovarian cancerEuropean Journal Of Cancer, 2000
- Centrosomal and Cytoplasmic Cdc2/Cyclin B1 Activation Precedes Nuclear Mitotic EventsExperimental Cell Research, 2000
- Dominant genetic alterations in immortalization: Role for 20q gainGenes, Chromosomes and Cancer, 1999
- Mammalian BUB1 Protein Kinases: Map Positions andin VivoExpressionGenomics, 1997
- 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cellsOncogene, 1997
- Use of a cDNA microarray to analyse gene expression patterns in human cancerNature Genetics, 1996
- The Role of Myb Proteins in Normal and Neoplastic Cell ProliferationCritical Reviews™ in Oncogenesis, 1994